health
LEO Pharma Receives Positive CHMP Opinion Recommending Anzupgo® (delgocitinib) Cream for Adolescents With Moderate to Severe Chronic Hand Eczema in the EU

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma receives positive CHMP opinion recomm. Anzupgo® (delgocitinib) cream for adolescents with moderate to severe chronic hand eczema in the EU
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
Businesswire

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
Businesswire
QT Imaging to be Honored at Premier’s Annual Supplier Innovation Celebration
Businesswire
China takes decisive action to advance global development
Pr Newswire Apac

Project RED Expands Oregon's Overdose Prevention Efforts with Support from Boulder Care and Pearl Jam’s Vitalogy Foundation
Businesswire